PerpEquities

Equity

Alnylam Pharmaceuticals, Inc. (ALNY) perpetual futures

ALNY perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade ALNYUSDT.

Alnylam Pharmaceuticals discovers, develops and commercializes RNAi-based therapies, including approved treatments ONPATTRO, GIVLAARI and OXLUMO, for genetic, cardio-metabolic, hepatic and CNS disorders.

$247.85-2.2%NASDAQ closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · MEXC (ALNY/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$81.7K
Open interest
$88.4K
Best liquidity
$5.9K
MEXC
Tightest spread
+190.8 bps
MEXC
Highest volume
$81.7K
MEXC
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $314.9M
OI / float
0.00%
Float $33B
Spot performance
1D-2.04%
5D+0.04%
1M+4.36%
6M-19.61%
YTD-38.01%
1Y-45.75%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeALNY/USDTTrading$247.85+21.9% APR
+0.020% every 8h
+190.8 bps$5.9K$81.7K$88.4KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

No fresh book data: MEXC

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

ALNY

Tightest spread

ALNY

Highest volume

ALNY

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 2h ago
Market cap
$33B
Updated 2h ago
Revenue
$4.8B
Trailing 12 months
Revenue growth
+47%
Next fiscal year
Profit margin
+16.8%
P/E
40.4
Peer P/E 19.4
Free cash flow
$542.5M
Trailing 12 months
More metrics
Net income
$808M
Trailing 12 months
P/S
6.9
Peer P/E
19.4
Similar listed perps
Revenue estimate
$5.5B
Next fiscal year
Earnings
2026-10-29
Revenue est. $1.4B · Updated 2h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$3.7B
Net margin+8.4%
Free cash flow$465.4M
Net debt-$378.9M
2020$492.9M
2021$844.3M
2022$1B
2023$1.8B
2024$2.2B
2025$3.7B
PeriodRevenueGrowthNet incomeFCF
2020$492.9M+124%-$858.3M-$685.3M
2021$844.3M+71%-$852.8M-$718.1M
2022$1B+23%-$1.1B-$613.3M
2023$1.8B+76%-$440.2M$41.9M
2024$2.2B+23%-$278.2M-$42.6M
2025$3.7B+65%$313.7M$465.4M
PeriodGross marginOperating marginNet marginROEROA
2020+84.2%-168.1%-174.1%-84.5%-25.2%
2021+83.4%-83.9%-101.0%-145.0%-23.4%
2022+83.7%-75.7%-109.0%+714.9%-31.9%
2023+83.0%-15.4%-24.1%+199.5%-11.5%
2024+85.6%-7.9%-12.4%-414.6%-6.6%
2025+81.8%+13.5%+8.4%+39.8%+6.3%
PeriodCashDebtNet debtCurrent ratio
2020$496.6M$521.2M$24.6M4.47
2021$820M$997.6M$177.6M4.04
2022$866.4M$1.3B$453.9M3.51
2023$812.7M$1.3B$492.7M3.08
2024$966.4M$1.3B$329.6M2.78
2025$1.7B$1.3B-$378.9M2.76
PeriodMarket capEnterprise valueP/SP/E
2020$14.9B$15B30.3-17.4
2021$20.1B$20.3B23.8-23.6
2022$28.9B$29.4B27.9-25.6
2023$23.9B$24.4B13.1-54.4
2024$30B$30.4B13.4-107.9
2025$52.1B$51.7B14.0166.4
Q3 2024$500.9M
Q4 2024$593.2M
Q1 2025$594.2M
Q2 2025$773.7M
Q3 2025$1.2B
Q4 2025$1.1B
Q1 2026$1.2B
Q2 2026$1.3B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$500.9M-33%-$111.6M$39.5M
Q4 2024$593.2M+35%-$83.8M-$103.8M
Q1 2025$594.2M+20%-$57.5M-$127.3M
Q2 2025$773.7M+17%-$66.3M$139.4M
Q3 2025$1.2B+149%$251.1M$313M
Q4 2025$1.1B+85%$186.4M$140.3M
Q1 2026$1.2B+96%$206M$48.7M
Q2 2026$1.3B+67%$164.5M$40.6M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+82.9%-15.4%-22.3%-344.8%-2.7%
Q4 2024+82.7%-17.7%-14.1%-124.9%-2.0%
Q1 2025+88.0%+3.0%-9.7%-49.8%-1.4%
Q2 2025+81.5%-2.1%-8.6%-26.4%-1.5%
Q3 2025+84.2%+29.5%+20.1%+107.3%+5.2%
Q4 2025+75.6%+12.0%+17.0%+23.6%+3.8%
Q1 2026+81.9%+23.0%+17.6%+19.2%+4.0%
Q2 2026+76.9%+17.9%+12.7%+12.1%+3.0%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$1.1B$1.3B$201.9M2.75
Q4 2024$966.4M$1.3B$329.6M2.78
Q1 2025$1B$1.3B$282M3.04
Q2 2025$1.1B$1.3B$183.4M2.80
Q3 2025$1.5B$1.3B-$181.8M2.54
Q4 2025$1.7B$1.3B-$378.9M2.76
Q1 2026$1.7B$1.3B-$437.7M3.13
Q2 2026$1.7B$1.3B-$440.9M3.05
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$35.4B$35.6B70.6-79.0
Q4 2024$30.3B$30.6B51.0-90.5
Q1 2025$35B$35.3B58.9-153.4
Q2 2025$42.3B$42.5B54.7-159.8
Q3 2025$59.9B$59.8B48.059.7
Q4 2025$52.6B$52.2B47.970.5
Q1 2026$44B$43.5B37.753.4
Q2 2026$40.1B$39.7B31.161.2

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$1.3BQ2 2026
$322.7M$645.5M$968.2M$1.3BQ3 2023: $750.5MQ4 2023: $439.7MQ1 2024: $494.3MQ2 2024: $659.8MQ3 2024: $500.9MQ4 2024: $593.2MQ1 2025: $594.2MQ2 2025: $773.7MQ3 2025: $1.2BQ4 2025: $1.1BQ1 2026: $1.2BQ2 2026: $1.3BQ3 2023Q2 2026
Net income$164.5MQ2 2026
-$40.6M$56.6M$153.8M$251.1MQ3 2023: $147.8MQ4 2023: -$137.9MQ1 2024: -$65.9MQ2 2024: -$16.9MQ3 2024: -$111.6MQ4 2024: -$83.8MQ1 2025: -$57.5MQ2 2025: -$66.3MQ3 2025: $251.1MQ4 2025: $186.4MQ1 2026: $206MQ2 2026: $164.5MQ3 2023Q2 2026
EBITDA$244.7MQ2 2026
-$29.6M$81.8M$193.1M$304.5MQ3 2023: $195MQ4 2023: -$92.9MQ1 2024: -$14.8MQ2 2024: $37.1MQ3 2024: -$60.3MQ4 2024: -$140.9MQ1 2025: $11.5MQ2 2025: $18.8MQ3 2025: $297.2MQ4 2025: $304MQ1 2026: $304.5MQ2 2026: $244.7MQ3 2023Q2 2026
Free cash flow$40.6MQ2 2026
-$9.9M$107.5M$224.9M$342.3MQ3 2023: $342.3MQ4 2023: -$45.1MQ1 2024: -$94.5MQ2 2024: $116.1MQ3 2024: $39.5MQ4 2024: -$103.8MQ1 2025: -$127.3MQ2 2025: $139.4MQ3 2025: $313MQ4 2025: $140.3MQ1 2026: $48.7MQ2 2026: $40.6MQ3 2023Q2 2026
EPS$1.2Q2 2026
-$0.37$0.37$1.11$1.84Q3 2023: $1.15Q4 2023: -$1.1Q1 2024: -$0.52Q2 2024: -$0.13Q3 2024: -$0.87Q4 2024: -$0.65Q1 2025: -$0.44Q2 2025: -$0.51Q3 2025: $1.84Q4 2025: $1.37Q1 2026: $1.51Q2 2026: $1.2Q3 2023Q2 2026
Cash / Debt$1.7BQ2 2026
$427.7M$855.4M$1.3B$1.7BQ3 2023 · Cash: $1BQ3 2023 · Debt: $1.3BQ4 2023 · Cash: $812.7MQ4 2023 · Debt: $1.3BQ1 2024 · Cash: $681.9MQ1 2024 · Debt: $1.3BQ2 2024 · Cash: $968.5MQ2 2024 · Debt: $1.3BQ3 2024 · Cash: $1.1BQ3 2024 · Debt: $1.3BQ4 2024 · Cash: $966.4MQ4 2024 · Debt: $1.3BQ1 2025 · Cash: $1BQ1 2025 · Debt: $1.3BQ2 2025 · Cash: $1.1BQ2 2025 · Debt: $1.3BQ3 2025 · Cash: $1.5BQ3 2025 · Debt: $1.3BQ4 2025 · Cash: $1.7BQ4 2025 · Debt: $1.3BQ1 2026 · Cash: $1.7BQ1 2026 · Debt: $1.3BQ2 2026 · Cash: $1.7BQ2 2026 · Debt: $1.3BQ3 2023Q2 2026
CashDebt
Profitability+76.9%Q2 2026
-1.1%+29.1%+59.4%+89.6%Q3 2023 · Gross margin: +88.8%Q4 2023 · Gross margin: +80.5%Q1 2024 · Gross margin: +86.7%Q2 2024 · Gross margin: +89.6%Q3 2024 · Gross margin: +82.9%Q4 2024 · Gross margin: +82.7%Q1 2025 · Gross margin: +88.0%Q2 2025 · Gross margin: +81.5%Q3 2025 · Gross margin: +84.2%Q4 2025 · Gross margin: +75.6%Q1 2026 · Gross margin: +81.9%Q2 2026 · Gross margin: +76.9%Q3 2023 · Operating margin: +28.5%Q4 2023 · Operating margin: -26.5%Q1 2024 · Operating margin: -8.8%Q2 2024 · Operating margin: +7.4%Q3 2024 · Operating margin: -15.4%Q4 2024 · Operating margin: -17.7%Q1 2025 · Operating margin: +3.0%Q2 2025 · Operating margin: -2.1%Q3 2025 · Operating margin: +29.5%Q4 2025 · Operating margin: +12.0%Q1 2026 · Operating margin: +23.0%Q2 2026 · Operating margin: +17.9%Q3 2023 · Net margin: +19.7%Q4 2023 · Net margin: -31.4%Q1 2024 · Net margin: -13.3%Q2 2024 · Net margin: -2.6%Q3 2024 · Net margin: -22.3%Q4 2024 · Net margin: -14.1%Q1 2025 · Net margin: -9.7%Q2 2025 · Net margin: -8.6%Q3 2025 · Net margin: +20.1%Q4 2025 · Net margin: +17.0%Q1 2026 · Net margin: +17.6%Q2 2026 · Net margin: +12.7%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+66.9%Q2 2026
+12.4%+58.0%+103.7%+149.3%Q3 2024: -33.3%Q4 2024: +34.9%Q1 2025: +20.2%Q2 2025: +17.3%Q3 2025: +149.3%Q4 2025: +84.9%Q1 2026: +96.4%Q2 2026: +66.9%Q3 2023Q2 2026
Shares outstanding138.2MQ2 2026
34.6M69.1M103.7M138.2MQ3 2023: 131.3MQ4 2023: 125.6MQ1 2024: 126.1MQ2 2024: 126.7MQ3 2024: 128.6MQ4 2024: 128.6MQ1 2025: 129.7MQ2 2025: 129.7MQ3 2025: 137.3MQ4 2025: 136.3MQ1 2026: 138.2MQ2 2026: 138.2MQ3 2023Q2 2026
Valuation61.2Q2 2026
-333.3-198.7-64.070.6Q3 2023 · P/E: 37.5Q4 2023 · P/E: -43.5Q1 2024 · P/E: -73.7Q2 2024 · P/E: -467.9Q3 2024 · P/E: -79.0Q4 2024 · P/E: -90.5Q1 2025 · P/E: -153.4Q2 2025 · P/E: -159.8Q3 2025 · P/E: 59.7Q4 2025 · P/E: 70.5Q1 2026 · P/E: 53.4Q2 2026 · P/E: 61.2Q3 2023 · P/S: 29.5Q4 2023 · P/S: 54.7Q1 2024 · P/S: 39.1Q2 2024 · P/S: 46.7Q3 2024 · P/S: 70.6Q4 2024 · P/S: 51.0Q1 2025 · P/S: 58.9Q2 2025 · P/S: 54.7Q3 2025 · P/S: 48.0Q4 2025 · P/S: 47.9Q1 2026 · P/S: 37.7Q2 2026 · P/S: 31.1Q3 2023Q2 2026
P/EP/S
Revenue$3.7B2025
$928.5M$1.9B$2.8B$3.7B2018: $74.9M2019: $219.8M2020: $492.9M2021: $844.3M2022: $1B2023: $1.8B2024: $2.2B2025: $3.7B20182025
Net income$313.7M2025
-$769.9M-$408.7M-$47.5M$313.7M2018: -$761.5M2019: -$886.1M2020: -$858.3M2021: -$852.8M2022: -$1.1B2023: -$440.2M2024: -$278.2M2025: $313.7M20182025
EBITDA$631.4M2025
-$537.1M-$147.6M$241.9M$631.4M2018: -$754.2M2019: -$868.1M2020: -$736.3M2021: -$661.6M2022: -$926.6M2023: -$258.2M2024: -$178.8M2025: $631.4M20182025
Free cash flow$465.4M2025
-$422.2M-$126.3M$169.5M$465.4M2018: -$689.5M2019: -$418.6M2020: -$685.3M2021: -$718.1M2022: -$613.3M2023: $41.9M2024: -$42.6M2025: $465.4M20182025
EPS$2.332025
-$6.39-$3.49-$0.58$2.332018: -$7.572019: -$8.112020: -$7.462021: -$7.22022: -$9.32023: -$3.522024: -$2.182025: $2.3320182025
Cash / Debt$1.7B2025
$414.3M$828.6M$1.2B$1.7B2018 · Cash: $420.1M2018 · Debt: $30M2019 · Cash: $547.2M2019 · Debt: $303.8M2020 · Cash: $496.6M2020 · Debt: $521.2M2021 · Cash: $820M2021 · Debt: $997.6M2022 · Cash: $866.4M2022 · Debt: $1.3B2023 · Cash: $812.7M2023 · Debt: $1.3B2024 · Cash: $966.4M2024 · Debt: $1.3B2025 · Cash: $1.7B2025 · Debt: $1.3B20182025
CashDebt
Profitability+81.8%2025
-791.3%-495.0%-198.7%+97.6%2018 · Gross margin: +97.6%2019 · Gross margin: +88.6%2020 · Gross margin: +84.2%2021 · Gross margin: +83.4%2022 · Gross margin: +83.7%2023 · Gross margin: +83.0%2024 · Gross margin: +85.6%2025 · Gross margin: +81.8%2018 · Operating margin: -1,087.6%2019 · Operating margin: -427.5%2020 · Operating margin: -168.1%2021 · Operating margin: -83.9%2022 · Operating margin: -75.7%2023 · Operating margin: -15.4%2024 · Operating margin: -7.9%2025 · Operating margin: +13.5%2018 · Net margin: -1,016.6%2019 · Net margin: -403.2%2020 · Net margin: -174.1%2021 · Net margin: -101.0%2022 · Net margin: -109.0%2023 · Net margin: -24.1%2024 · Net margin: -12.4%2025 · Net margin: +8.4%20182025
Gross marginOperating marginNet margin
Revenue growth+65.2%2025
+48.3%+96.7%+145.0%+193.4%2019: +193.4%2020: +124.3%2021: +71.3%2022: +22.9%2023: +76.2%2024: +23.0%2025: +65.2%20182025
Shares outstanding134.7M2025
33.7M67.3M101M134.7M2018: 100.6M2019: 109.3M2020: 115M2021: 118.5M2022: 121.7M2023: 124.9M2024: 127.7M2025: 134.7M20182025
Valuation166.42025
-39.429.297.8166.42018 · P/E: -9.62019 · P/E: -14.22020 · P/E: -17.42021 · P/E: -23.62022 · P/E: -25.62023 · P/E: -54.42024 · P/E: -107.92025 · P/E: 166.42018 · P/S: 97.92019 · P/S: 57.32020 · P/S: 30.32021 · P/S: 23.82022 · P/S: 27.92023 · P/S: 13.12024 · P/S: 13.42025 · P/S: 14.020182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-29
Revenue est. $1.4B · Updated 2h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20266.67$5.5B+47%15
FY 202710.08$6.9B+87%15
FY 202812.51$8.3B+123%17
FY 202914.37$9.3B+151%12
FY 203016.10$10.5B+184%7
Q1 20272.14$1.6B+39%8

Company events

6
2026-10-29EarningsActual - / Estimate 1.77-
2026-07-30EarningsActual 1.21 / Estimate 1.63Miss
2026-04-30EarningsActual 1.51 / Estimate 0.87Beat
2026-02-12EarningsActual 0.82 / Estimate 1.16Miss
2025-10-30EarningsActual 1.84 / Estimate 0.56Beat
2025-07-31EarningsActual -0.51 / Estimate -0.54Beat

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering ALNY have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings192622
Analysts3441
Buy / hold / sell158 / 34 / 0490 / 131 / 1
Upgrades / downgrades / initiations0 / 1 / 34 / 4 / 12
Price targets hit / missed2 / 169 (1%)97 / 465 (17%)
Avg. return after a rating (TipRanks)-43.2%-22.7%
Best / worst call+7.1% / -57.6%+97.0% / -57.8%

After buy calls on this stock: not enough measured cases yet

Latest ratings

DateAnalystCallTarget
Sep 21, 2026Patrick TrucchioH.C. WainwrightBuyReiterated$455
Sep 17, 2026David LebowitzBMO CapitalBuyMaintained$318
Sep 18, 2026Danielle BrillTruist FinancialBuyReiterated
Sep 17, 2026Joseph StringerNeedhamBuyMaintained$357
Sep 16, 2026Jeffrey WalchBernsteinBuyMaintained$376

TipRanks data via FMP · computed Sep 23, 2026 · 192 ratings

Frequently asked questions

Where can I trade ALNY perpetual futures?

Alnylam Pharmaceuticals, Inc. (ALNY) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade ALNY around the clock?

Yes. Unlike the underlying stock, ALNY perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on ALNY perpetuals?

Right now the ALNY perp funding rate is +21.9% annualized (venue median), ranging from +21.9% to +21.9% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the ALNY perp price compare to the Alnylam Pharmaceuticals, Inc. stock?

The venue-median ALNY perp mark is $247.9 versus a reference stock price of $247.9, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a ALNY perpetual future?

A ALNY perpetual is a derivative that tracks the price of Alnylam Pharmaceuticals, Inc. with no expiry date. It lets you take long or short exposure to Alnylam Pharmaceuticals, Inc. on crypto venues, around the clock.

What is ALNYUSDT perpetual?

ALNYUSDT is the symbol most crypto exchanges use for the Alnylam Pharmaceuticals, Inc. perpetual settled in USDT (Tether). It tracks the ALNY share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

ALNY perpetuals · perpequities.comALNY perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/alny-perp"><img src="https://perpequities.com/badge/alny-perp.svg" width="240" height="64" alt="ALNY perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of ALNY perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for ALNY — one email every Sunday.

Watchlist and alerts

Price and funding alerts for ALNY, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X